SCM
PFE icon

SKBA Capital Management’s Pfizer PFE Stock Holding History

SKBA Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Sell
425,750
-70,000
-14% -$1.83M 1.69% 30
2026
Q1 		$13.9M Hold
495,750
– – 1.91% 21
2025
Q4 		$12.3M Buy
495,750
+3,300
+0.7% +$83.2K 1.75% 29
2025
Q3 		$12.5M Sell
492,450
-3,100
-0.6% -$76.5K 1.73% 28
2025
Q2 		$12M Buy
495,550
+47,200
+11% +$1.1M 1.73% 28
2025
Q1 		$11.4M Sell
448,350
-1,900
-0.4% -$49.7K 1.69% 23
2024
Q4 		$11.9M Buy
450,250
+21,400
+5% +$580K 1.89% 20
2024
Q3 		$12.4M Buy
428,850
+17,000
+4% +$496K 1.84% 20
2024
Q2 		$11.5M Buy
411,850
+97,750
+31% +$2.69M 1.85% 24
2024
Q1 		$8.72M Buy
314,100
+19,500
+7% +$541K 1.36% 39
2023
Q4 		$8.48M Buy
+294,600
New +$8.91M 1.43% 40
2023
Q1 		– Sell
-7,000
Closed -$359K – 78
2022
Q4 		$359K Hold
7,000
– – 0.07% 62
2022
Q3 		$306K Sell
7,000
-3,450
-33% -$168K 0.06% 64
2022
Q2 		$548K Hold
10,450
– – 0.11% 55
2022
Q1 		$541K Sell
10,450
-700
-6% -$36.3K 0.1% 56
2021
Q4 		$658K Sell
11,150
-2,100
-16% -$104K 0.12% 53
2021
Q3 		$570K Buy
13,250
+100
+0.8% +$4.43K 0.11% 57
2021
Q2 		$515K Buy
13,150
+2,050
+18% +$79.7K 0.1% 58
2021
Q1 		$402K Sell
11,100
-1,150
-9% -$40.8K 0.06% 64
2020
Q4 		$451K Buy
12,250
+5,399
+79% +$198K 0.08% 58
2020
Q3 		$239K Buy
+6,851
New +$240K 0.05% 67
2014
Q2 		– Sell
-472,347
Closed -$14.4M – 96
2014
Q1 		$14.4M Buy
472,347
+93,911
+25% +$2.8M 1.34% 38
2013
Q4 		$11M Sell
378,436
-8,745
-2% -$255K 1.28% 38
2013
Q3 		$10.6M Sell
387,181
-100,867
-21% -$2.74M 1.28% 41
2013
Q2 		$13M Buy
+488,048
New +$13.5M 1.53% 31

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SKBA Capital Management's PFE Position: Q2 2026 in Review

SKBA Capital Management reduced its Pfizer (PFE) stake by 14% in Q2 2026, selling an estimated $1.83M and leaving 425,750 shares worth $10.3M. The position accounts for 1.69% of the portfolio, ranked #30.

SKBA Capital Management first reported a position in PFE in Q2 2013 and has held it in 25 quarters since. The position peaked at $14.4M in Q1 2014. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • SKBA Capital Management held 425,750 shares of Pfizer worth $10.3M as of Q2 2026.
  • SKBA Capital Management sold 70,000 Pfizer shares in Q2 2026, an estimated $1.83M.
  • Pfizer made up 1.69% of SKBA Capital Management's portfolio in Q2 2026, its #30 holding.
  • SKBA Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 25 quarters since.
  • SKBA Capital Management's Pfizer position peaked at $14.4M in Q1 2014.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on SKBA Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.